fbpx
Advertisement
Advertisement

Pakistan to start manufacturing COVID-19 treatment drug soon: Dr. Zafar

CoronavirusPakistan to start manufacturing COVID-19 treatment drug soon: Dr. Zafar
Advertisement

ISLAMABAD, Pakistan: The Prime Minister’s Special Assistant on National Health Services Dr. Zafar Mirza has said that Pakistan will soon start manufacturing breakthrough COVID-19 treatment drug Remdesivir under a license from the US Pharmaceutical Company Gilead.

While addressing a news conference in Islamabad on Friday, he said that a Pakistani Pharmaceutical Company has concluded its voluntary licensing agreement with the US Pharmaceutical Company Gilead for the manufacturing and sale of Remdesivir.

Advertisement

The Special Assistant said that Pakistan is among the five Countries with which the US Company has signed a licensing agreement for manufacturing the drug.COVID-19 treatment drug - The Prime Minister’s Special Assistant on National Health Services Dr. Zafar Mirza has said that Pakistan will soon start manufacturing breakthrough COVID-19 treatment drug Remdesivir under a license from the US Pharmaceutical Company Gilead. While addressing a news conference in Islamabad on Friday, he said that a Pakistani Pharmaceutical Company has concluded its voluntary licensing agreement with the US Pharmaceutical Company Gilead for the manufacturing and sale of Remdesivir. The Special Assistant said that Pakistan is among the five Countries with which the US Company has signed licensing agreement for manufacturing the drug. Dr. Zafar Mirza said that the production of the medicine can commence as early as eight weeks after the necessary regulatory approvals are obtained. Furthermore, he said that the development represents an important step forward for Pakistan on the health, economic and diplomacy fronts. The Special Assistant said that it helps provide our citizens and frontline healthcare workers access to the latest treatment for the pandemic in a fast-track manner. Dr. Zafar Mirza said that Pakistan will also be able to export the medicine to 127 Countries facing Coronavirus pandemic.

Dr. Zafar Mirza said that the production of the medicine can commence as early as eight weeks after the necessary regulatory approvals are obtained.

Furthermore, he said that the development represents an important step forward for Pakistan on the health, economic and diplomacy fronts.

Advertisement


The Special Assistant said that it helps provide our citizens and frontline healthcare workers access to the latest treatment for the pandemic in a fast-track manner.

Dr. Zafar Mirza said that Pakistan will also be able to export the medicine to 127 Countries facing Coronavirus pandemic.

Advertisement
Mati
Mati
Mati-Ullah is the Online Editor For DND. He is the real man to handle the team around the Country and get news from them and provide to you instantly.

Must read

Recent News

Turkish Lira to PKR: TRY Rate in Pakistan on 21 March 2023

0
The Turkish Lira (TRY) was equal to Rs 14.93 against the Pakistani Rupee (PKR) on Monday. Turkish Lira to PKR - TRY Rate in Pakistan...

AED to PKR: UAE Dirham Rate in Pakistan on 21 March 2023

0
The United Arab Emirates Dirham (AED) gained 0.63 paisas against the Pakistani Rupee (PKR) in the Interbank Market on Monday.At the Closing of the...

USD to PKR: US Dollar Rate in Pakistan on 21 March 2023

0
The US Dollar (USD) once again gained Rs 2.32 against the Pakistani Rupee (PKR) on Monday to settle at Rs 284.03, appreciating by 0.82...

Journalist Siddique Jan arrested in Islamabad

0
ISLAMABAD, Pakistan: The Journalist and Bol News Islamabad Bureau Chief Siddique Jan has been arrested from Islamabad on Monday night.Siddique Jan was arrested from...

Neha Mankani named as US Mission Pakistan’s 2023 “Woman of Courage”

0
ISLAMABAD, Pakistan: The US Mission Pakistan Deputy Chief of Mission Andrew Schofer named Pakistani midwife Neha Mankani as the US Mission Pakistan’s 2023 “Woman...
Advertisement